Ποια είναι η τιμή για VentriPoint Diagnostics Ltd. (VPT)

Η τιμή για VentriPoint Diagnostics Ltd. (VPT) είναι $0.07706337

Ποια είναι η κεφαλαιοποίηση αγοράς για VentriPoint Diagnostics Ltd. (VPT)

Η κεφαλαιοποίηση αγοράς για VentriPoint Diagnostics Ltd. (VPT) είναι $14.46M

VentriPoint Diagnostics Ltd. (VPT) Τιμή και Κεφαλαιοποίηση Αγοράς

VentriPoint Diagnostics Ltd. is a medical technology company focused on developing and commercializing diagnostic tools worldwide. These innovative solutions are designed to monitor individuals afflicted with cardiovascular disease. At the core of their offerings is the Ventripoint Medical System (VMS), an advanced medical imaging platform. The VMS generates precise three-dimensional models of the heart's chambers, providing crucial volumetric and functional measurements. This system is further enhanced by its VMS+ software, which processes echocardiogram and magnetic resonance imaging (MRI) data to construct these 3D models. The VMS+ software ensures highly reproducible and accurate quantification of heart chamber volumes and ejection fraction. Beyond its current flagship system, VentriPoint Diagnostics is actively expanding its portfolio with a suite of specialized applications. These applications target various cardiac conditions and imaging techniques, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and heart complications stemming from Covid-19. Founded in 2004, the company operates from its headquarters in Toronto, Canada.

Η τιμή για VPT	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$28,277.75 $14.46M	NVDA	$5.307T	+36,694,046.27%
$24,249.97 $14.46M	AAPL	$4.551T	+31,467,474.98%
$22,137.80 $14.46M	GOOG	$4.154T	+28,726,651.69%
$19,122.68 $14.46M	MSFT	$3.589T	+24,814,120.27%
$14,903.86 $14.46M	AMZN	$2.797T	+19,339,644.13%

Η τιμή για VPT

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$28,277.75 $14.46M